What is the best choice of follow-up procedure following resection of lung cancer?

Affiliations

¹ Klinik für Strahlentherapie und Radiologische Onkologie, Kliniken Maria Hilf, Mönchengladbach 41063, Germany; Department of Radiation Oncology, Medical Faculty Medical Center, University of Freiburg, Germany. Electronic address: ursula.nestle@mariahilf.de.
² Division of Radiology, German Cancer Research Center, Heidelberg, Germany.

Comment

Ursula Nestle et al. Lancet Oncol. 2022 Sep.

. 2022 Sep;23(9):1115-1116.

doi: 10.1016/S1470-2045(22)00499-5. Epub 2022 Aug 11.

¹ Klinik für Strahlentherapie und Radiologische Onkologie, Kliniken Maria Hilf, Mönchengladbach 41063, Germany; Department of Radiation Oncology, Medical Faculty Medical Center, University of Freiburg, Germany. Electronic address: ursula.nestle@mariahilf.de.
² Division of Radiology, German Cancer Research Center, Heidelberg, Germany.

No abstract available

Conflict of interest statement

UN has received institutional grants from AstraZeneca and MSD. SD declares no competing interests.

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Westeel V, Foucher P, Scherpereel A, Domas J, Girard P, Trédaniel J, Wislez M, Dumont P, Quoix E, Raffy O, Braun D, Derollez M, Goupil F, Hermann J, Devin E, Barbieux H, Pichon E, Debieuvre D, Ozenne G, Muir JF, Dehette S, Virally J, Grivaux M, Lebargy F, Souquet PJ, Freijat FA, Girard N, Courau E, Azarian R, Farny M, Duhamel JP, Langlais A, Morin F, Milleron B, Zalcman G, Barlesi F. Westeel V, et al. Lancet Oncol. 2022 Sep;23(9):1180-1188. doi: 10.1016/S1470-2045(22)00451-X. Epub 2022 Aug 11. Lancet Oncol. 2022. PMID: 35964621 Clinical Trial.